Why B.C. Needs an Innovation Box — and We Shouldn't Stop at Life Sciences

By Kiersten Enemark
CCI's Director of B.C. Affairs

British Columbia excels at innovation but loses momentum at the commercialization stage, allowing jobs and prosperity to flow elsewhere. Our universities regularly produce world-class technology. But commercialization, not invention, is what creates jobs and government tax revenue. It turns startups into anchor tech companies that drive job growth and help the province reach its ambitious goal of 400,000 new tech jobs over the next 10 years (a topic I recently wrote about in Vancouver Tech Journal). Yet commercialization is where B.C. keeps stalling: companies built here often take root and commercialize somewhere else, frequently just across the border.

Tax incentives are one of government’s most effective tools for shaping markets. Done well, they change where a company and its investors choose to build, hire, and stay. That’s exactly the lever B.C. needs to pull now. It’s time to not only reward invention, but to also ensure there’s a payoff for scaling and staying at home. Recognizing the power of tax incentives, the province concluded its consultation on a patent box for the life sciences sector. But the province shouldn't stop at patents, nor should government stop at the life sciences sector. B.C. has a clear opportunity to close the commercialization gap throughout the tech sector by adopting a tool already standard in many advanced innovation economies: an Innovation Box.
‍

The Missing Piece in B.C.'s Innovation Toolkit

For decades, B.C. has relied on the Scientific Research and Experimental Development (SR&ED) credit to encourage companies to take on the cost and risk of R&D. SR&ED rewards the invention of new ideas. It does nothing to reward what happens next: turning that invention into a commercialized product that is headquartered and taxed in British Columbia.

That gap matters. Canada has a well-documented pattern of generating world-class research and then watching the commercial value leave the country — through acquisition, relocation, or being outcompeted by jurisdictions offering a more attractive home for intellectual property. More than a dozen EU countries, plus the UK, China, and Australia, already use "patent box" or "innovation box" regimes to close this gap: a preferential tax rate on profits clearly tied to IP developed and commercialized domestically. Quebec has one. B.C. does not.

With the province currently consulting on a possible Innovation Box for life sciences and biotechnology, there is a real opportunity here, but only if it is designed well.
‍

Getting the Design Right

A few principles should anchor B.C.'s approach:

Don't limit "IP" to patents. In biotech especially, much of what makes a company valuable never gets patented — trade secrets, proprietary algorithms, data pipelines, even plant varieties. Patents are expensive, slow, and require public disclosure, which isn’t always the right choice for a fast-moving company. A box that only rewards patents will miss much of the innovation it’s meant to protect.

Keep the math simple. Profits genuinely tied to B.C.-based IP and B.C.-based R&D should qualify for a reduced rate — in the 2–6% range, to stay competitive with Quebec and international peers. The clearer and simpler the calculation, the more companies will use it.

Build it on top of what already exists. Awareness is often a bigger barrier to uptake than eligibility. Quebec’s experience shows that a good incentive can sit underused simply because companies don’t know it exists or don’t understand whether they qualify. B.C. should let a firm’s existing SR&ED claim serve as the “ticket” into the Innovation Box — reusing the CRA’s technical review instead of creating a new bureaucratic gate, and having Innovate BC actively promote it.

Protect the box from being gamed. A two-tier structure — as used in Ireland and the Netherlands — would apply tighter scrutiny to large multinationals while giving smaller, high-growth domestic firms more flexibility to include unpatented, trade-secret-protected IP, provided it’s backed by a genuine SR&ED claim. That keeps the incentive focused on the companies B.C. most needs to retain, not on profit-shifting by firms that were never going to leave anyway.
‍

Don't Stop at Life Sciences

Here's the part that matters most: no country in the world limits its patent box to a single sector, and for good reason. B.C. would have to invent its own definition of what counts as "medical" or "biotech" IP — a genuinely hard line to draw, especially for computational biosciences, medtech, or trade secrets that don't map cleanly onto existing patent classification systems. That's a lot of administrative complexity for very little upside.

The better path is a phased one: launch the Innovation Box in life sciences, where the case for urgency is clearest, but commit now to expanding it to other sectors — clean tech, AI, advanced manufacturing, robotics — once the model proves itself. B.C.'s innovation economy isn't confined to one industry, and the incentive to keep IP and jobs at home shouldn't be either.
‍

The Cost of Waiting

Every year B.C. goes without a competitive answer to jurisdictions actively courting our IP-heavy companies is another year that value walks out the door — acquired, relocated, or simply built elsewhere from the start. An Innovation Box won’t fix that on its own, but paired with SR&ED and built with the right guardrails, it sends a clear signal that if you invent it here, you should be able to build the company around it here too.

B.C. has a chance to lead on this. The question isn’t whether an Innovation Box makes sense. The international evidence already answers that. The question is whether B.C. designs one ambitious enough, and broad enough, to actually keep our best companies anchored here at home.

‍

About the Council of Canadian Innovators (CCI)

The Council of Canadian Innovators (CCI) is Canada’s business council for the 21st century economy. We are a collective of over 175 of Canada’s fastest-growing and most ambitious companies, and the founders, CEOs, and executives behind them, working together to improve the business conditions that help more homegrown companies scale, compete globally, and drive long-term prosperity.